Leveraging my network and language proficiency, I will directly communicate with experts, practitioners, and researchers in China specializing in traditional Chinese medicine, particularly in addiction treatment. This approach aims to obtain in-depth insights into the manufacturing, ingredients, prescriptions, and contacts related to U'finer capsule, Jitai tablet, and Keduning. I will initiate contact with reputable institutions, pharmaceutical manufacturers, and distributors in China associated with these medicines. By establishing communication channels and leveraging industry connections, I aim to gather detailed information on formulas, ingredients, prescribing practices, and contact details. I will delve beyond publicly accessible platforms like PubMed and NCBI, exploring specialized databases, research papers, and publications specific to traditional Chinese patent medicines for addiction. This targeted approach seeks to unveil comprehensive details about the formulations, research methodologies, and prescription processes of these medicines. I will strive to elucidate the process from the inception of patent medicine formulations to the point of prescription, meticulously detailing the steps involved in research, formulation discovery, regulatory approvals, and clinical practices leading to prescription by healthcare professionals.